Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332 (14 January), doi:10.1136/bmj.332.7533.0-d
A clinical review of gastro-oesophageal reflux disease (GORD) on p 88 finds enough evidence on the use of acid suppression in patients with "typical reflux symptoms" but only a few large and well done studies investigating patients with atypical symptoms and non-erosive oesophagitis, in whom acid suppression is less effective. Fox and Forgacs explain why the approach has shifted to looking at GORD as a family of diseases. The new model shifts attention to oesophageal symptoms, rather than injury to the oesophageal mucosa, and the corresponding shift in the NICE guidelines to "treat first, endoscope later" should benefit endoscopy negative patients with severe symptoms, they say.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?